{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:04:59Z","timestamp":1771826699806,"version":"3.50.1"},"reference-count":42,"publisher":"Jaypee Brothers Medical Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.59556\/japi.74.1294","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:16:38Z","timestamp":1771823798000},"page":"15-18","source":"Crossref","is-referenced-by-count":0,"title":["The Mechanism of Action of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction"],"prefix":"10.59556","volume":"74","author":[{"given":"RR","family":"Mantri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agam","family":"Vora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Raval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RS","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin K","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhamoy","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"SV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailash","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnamoorthy","family":"S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khizer H","family":"Junaidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Febin","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarnath","family":"Sugumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthilnathan","family":"Mohanasundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"issue":"(1):","key":"key20260223051631_B1","doi-asserted-by":"crossref","first-page":"37\u2013","DOI":"10.1007\/s40620-019-00600-7","article-title":"New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure.","volume":"33","author":"Capelli","year":"2020;","journal-title":"J Nephrol"},{"issue":"(5):","key":"key20260223051631_B2","doi-asserted-by":"crossref","first-page":"H958\u2013","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: going beyond the classical paradigms.","volume":"316","author":"Santos","year":"2019;","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key20260223051631_B3","doi-asserted-by":"crossref","unstructured":"Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models. Accessed July 2, 2025. https:\/\/www.mdpi.com\/1422-0067\/25\/16\/9088","DOI":"10.3390\/ijms25169088"},{"issue":"(1):","key":"key20260223051631_B4","doi-asserted-by":"crossref","first-page":"19\u2013","DOI":"10.1016\/j.kisu.2021.11.001","article-title":"Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms.","volume":"12","author":"Bauersachs","year":"2022;","journal-title":"Kidney Int Suppl"},{"issue":"(2):","key":"key20260223051631_B5","doi-asserted-by":"crossref","first-page":"755.","DOI":"10.1378\/chest.122.2.755","article-title":"Renin-angiotensin-aldosterone activation in heart failure, aldosterone escape.","volume":"122","author":"Andrew","year":"2002;","journal-title":"Chest"},{"issue":"(1):","key":"key20260223051631_B6","doi-asserted-by":"crossref","first-page":"297\u2013","DOI":"10.1152\/physrev.00011.2014","article-title":"Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited.","volume":"95","author":"Rossier","year":"2015;","journal-title":"Physiol Rev"},{"issue":"(2):","key":"key20260223051631_B7","doi-asserted-by":"crossref","first-page":"168\u2013","DOI":"10.1016\/j.mce.2011.07.020","article-title":"Tissue-specific modulation of mineralocorticoid receptor function by 11\u03b2-hydroxysteroid dehydrogenases: an overview.","volume":"350","author":"Odermatt","year":"2012;","journal-title":"Mol Cell Endocrinol"},{"key":"key20260223051631_B8","first-page":"37\u2013","volume-title":"Vitamins and Hormones.","author":"Fuller","year":"2019."},{"issue":"(10):","key":"key20260223051631_B9","doi-asserted-by":"crossref","first-page":"1051\u2013","DOI":"10.1038\/ki.2011.48","article-title":"Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease.","volume":"79","author":"Bertocchio","year":"2011;","journal-title":"Kidney Int"},{"issue":"(9):","key":"key20260223051631_B10","doi-asserted-by":"crossref","first-page":"2395.","DOI":"10.1097\/01.ASN.0000086472.65806.73","article-title":"Aldosterone in chronic kidney and cardiac disease.","volume":"14","author":"Hostetter","year":"2003;","journal-title":"J Am Soc Nephrol"},{"issue":"(4):","key":"key20260223051631_B11","doi-asserted-by":"crossref","first-page":"679\u2013","DOI":"10.1161\/HYPERTENSIONAHA.110.164962","article-title":"The mineralocorticoid receptor in heart.","volume":"57","author":"Jaisser","year":"2011;","journal-title":"Hypertension"},{"issue":"(1):","key":"key20260223051631_B12","doi-asserted-by":"crossref","first-page":"98\u2013","DOI":"10.1038\/ki.1982.14","article-title":"Plasma aldosterone concentrations in chronic renal disease.","volume":"21","author":"Hen\u00e9","year":"1982;","journal-title":"Kidney Int"},{"issue":"(5):","key":"key20260223051631_B13","doi-asserted-by":"crossref","first-page":"393\u2013","DOI":"10.1016\/j.pcad.2009.12.003","article-title":"Aldosterone and mineralocorticoid receptors in the cardiovascular system.","volume":"52","author":"Funder","year":"2010;","journal-title":"Prog Cardiovasc Dis"},{"issue":"(4):","key":"key20260223051631_B14","doi-asserted-by":"crossref","first-page":"746\u2013","DOI":"10.1161\/HYPERTENSIONAHA.110.163287","article-title":"Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function.","volume":"57","author":"Lother","year":"2011;","journal-title":"Hypertension"},{"issue":"(4):","key":"key20260223051631_B15","doi-asserted-by":"crossref","first-page":"400\u2013","DOI":"10.1161\/CIRCULATIONAHA.110.983023","article-title":"Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction.","volume":"123","author":"Fraccarollo","year":"2011;","journal-title":"Circulation"},{"issue":"(26):","key":"key20260223051631_B16","doi-asserted-by":"crossref","first-page":"3066\u2013","DOI":"10.1016\/j.lfs.2005.12.011","article-title":"Regulation of cardiac and renal mineralocorticoid receptor expression by captopril following myocardial infarction in rats.","volume":"78","author":"De Resende","year":"2006;","journal-title":"Life Sci"},{"issue":"(23):","key":"key20260223051631_B17","doi-asserted-by":"crossref","first-page":"3025\u2013","DOI":"10.1161\/CIRCULATIONAHA.104.503706","article-title":"Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias.","volume":"111","author":"Ouvrard-Pascaud","year":"2005;","journal-title":"Circulation"},{"issue":"(5):","key":"key20260223051631_B18","doi-asserted-by":"crossref","first-page":"427\u2013","DOI":"10.1291\/hypres.30.427","article-title":"Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11\u03b2-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.","volume":"30","author":"Takeda","year":"2007;","journal-title":"Hypertens Res"},{"issue":"(10):","key":"key20260223051631_B19","doi-asserted-by":"crossref","first-page":"6656\u2013","DOI":"10.1074\/jbc.M113.519256","article-title":"The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation*.","volume":"289","author":"Lavall","year":"2014;","journal-title":"J Biol Chem"},{"issue":"(10):","key":"key20260223051631_B20","doi-asserted-by":"crossref","first-page":"1435\u2013","DOI":"10.1161\/CIRCULATIONAHA.105.539122","article-title":"Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.","volume":"112","author":"Quinkler","year":"2005;","journal-title":"Circulation"},{"issue":"(6):","key":"key20260223051631_B21","doi-asserted-by":"crossref","first-page":"H2372\u2013","DOI":"10.1152\/ajpheart.00283.2011","article-title":"A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.","volume":"301","author":"L\u00f3pez-Andr\u00e9s","year":"2011;","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"(1):","key":"key20260223051631_B22","doi-asserted-by":"crossref","first-page":"41\u2013","DOI":"10.1007\/s10157-010-0373-1","article-title":"Aldosterone-induced kidney injury is mediated by NF\u03baB activation.","volume":"15","author":"Fukuda","year":"2011;","journal-title":"Clin Exp Nephrol"},{"issue":"(1-3):","key":"key20260223051631_B23","doi-asserted-by":"crossref","first-page":"264\u2013","DOI":"10.1016\/j.ejphar.2008.06.019","article-title":"Spironolactone exhibits direct renoprotective effects and inhibits renal renin\u2013angiotensin\u2013aldosterone system in diabetic rats.","volume":"589","author":"Taira","year":"2008;","journal-title":"Eur J Pharmacol"},{"issue":"(2):","key":"key20260223051631_B24","doi-asserted-by":"crossref","first-page":"140\u2013","DOI":"10.1097\/FJC.0b013e318258f8ce","article-title":"Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.","volume":"60","author":"Noda","year":"2012;","journal-title":"J Cardiovasc Pharmacol"},{"issue":"(5):","key":"key20260223051631_B25","doi-asserted-by":"crossref","first-page":"537\u2013","DOI":"10.1111\/jce.12379","article-title":"Eplerenone-mediated regression of electrical activation delays and myocardial fibrosis in heart failure.","volume":"25","author":"Tanaka-Esposito","year":"2014;","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"(2):","key":"key20260223051631_B26","doi-asserted-by":"crossref","first-page":"246\u2013","DOI":"10.1007\/s00125-023-06031-1","article-title":"Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists.","volume":"67","author":"Savarese","year":"2024;","journal-title":"Diabetologia"},{"issue":"(9S):","key":"key20260223051631_B27","doi-asserted-by":"crossref","first-page":"40\u2013","DOI":"10.59556\/japi.72.0678","article-title":"Fixed-dose combination of torsemide and mineralocorticoid receptor antagonists.","volume":"72","author":"Banerjee","year":"2024;","journal-title":"J Assoc Physicians India"},{"issue":"(4):","key":"key20260223051631_B28","first-page":"695\u2013","article-title":"Mineralocorticoid receptor.","volume":"67","author":"Nishiyama","year":"2009;","journal-title":"Nihon Rinsho Jpn J Clin Med"},{"issue":"(3):","key":"key20260223051631_B29","doi-asserted-by":"crossref","first-page":"341\u2013","DOI":"10.1002\/ddr.21760","article-title":"Role of mineralocorticoid receptor antagonists in kidney diseases.","volume":"82","author":"Patel","year":"2021;","journal-title":"Drug Dev Res"},{"issue":"(4):","key":"key20260223051631_B30","first-page":"335\u2013","article-title":"Mineralocorticoid receptor antagonists: a new therapeutic option for diabetic kidney disease.","volume":"39","author":"Girerd","year":"2023;","journal-title":"Med Sci"},{"issue":"(3):","key":"key20260223051631_B31","doi-asserted-by":"crossref","first-page":"285.","DOI":"10.1097\/CRD.0000000000000548","article-title":"Finerenone: efficacy of a new nonsteroidal mineralocorticoid receptor antagonist in treatment of patients with chronic kidney disease and type 2 diabetes.","volume":"32","author":"Dey","year":"2024;","journal-title":"Cardiol Rev"},{"issue":"(9):","key":"key20260223051631_B32","doi-asserted-by":"crossref","first-page":"884\u2013","DOI":"10.1001\/jama.2015.10081","article-title":"Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial.","volume":"314","author":"Bakris","year":"2015;","journal-title":"JAMA"},{"issue":"(5):","key":"key20260223051631_B33","doi-asserted-by":"crossref","first-page":"333\u2013","DOI":"10.1159\/000503713","article-title":"Design and baseline characteristics of the finerenone in reducing kidney failure and disease progression in diabetic kidney disease trial.","volume":"50","author":"Bakris","year":"2019;","journal-title":"Am J Nephrol"},{"issue":"(3):","key":"key20260223051631_B34","doi-asserted-by":"crossref","first-page":"107\u2013","DOI":"10.1097\/CRD.0000000000000286","article-title":"Mineralocorticoid receptor antagonist use in heart failure with reduced ejection fraction and end-stage renal disease patients on dialysis: a literature review.","volume":"28","author":"Bhinder","year":"2020;","journal-title":"Cardiol Rev"},{"issue":"(10):","key":"key20260223051631_B35","doi-asserted-by":"crossref","first-page":"709\u2013","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure.","volume":"341","author":"Pitt","year":"1999;","journal-title":"N Engl J Med"},{"issue":"(14):","key":"key20260223051631_B36","doi-asserted-by":"crossref","first-page":"1309\u2013","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003;","journal-title":"N Engl J Med"},{"issue":"(1):","key":"key20260223051631_B37","doi-asserted-by":"crossref","first-page":"11\u2013","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms.","volume":"364","author":"Zannad","year":"2011;","journal-title":"N Engl J Med"},{"key":"key20260223051631_B38","doi-asserted-by":"crossref","first-page":"78\u2013","DOI":"10.1016\/j.coph.2016.02.005","article-title":"Mineralocorticoid receptor antagonists\u2014pharmacodynamics and pharmacokinetic differences.","volume":"27:","author":"Yang","year":"2016;","journal-title":"Curr Opin Pharmacol"},{"issue":"(4):","key":"key20260223051631_B39","doi-asserted-by":"crossref","first-page":"153\u2013","DOI":"10.1002\/clc.20324","article-title":"A comparison of the aldosteroneblocking agents eplerenone and spironolactone-.","volume":"31","author":"Struthers","year":"2008;","journal-title":"Clin Cardiol"},{"key":"key20260223051631_B40","unstructured":"Mineralocorticoid Receptor Antagonists in Essential and Resistant\u2026: Ingenta Connect. Accessed July 3, 2025. https:\/\/www.ingentaconnect.com\/content\/ben\/cpd\/2018\/00000024\/00000046\/art00004"},{"issue":"(12):","key":"key20260223051631_B41","doi-asserted-by":"crossref","first-page":"2274\u2013","DOI":"10.1093\/clinchem\/43.12.2274","article-title":"Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia.","volume":"43","author":"Takamura","year":"1997;","journal-title":"Clin Chem"},{"issue":"(11):","key":"key20260223051631_B42","doi-asserted-by":"crossref","first-page":"1448\u2013","DOI":"10.1124\/dmd.31.11.1448","article-title":"Pharmacokinetics and metabolism of [14C]eplerenone after oral administration to humans.","volume":"31","author":"Cook","year":"2003;","journal-title":"Drug Metab Dispos"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:16:45Z","timestamp":1771823805000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-74-1-s1-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.59556\/japi.74.1294"],"URL":"https:\/\/doi.org\/10.59556\/japi.74.1294","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}